Explain this page
Arphra AIPlain-English read on X4 Pharmaceuticals, Inc.’s valuationNo recent stories.
today
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $12.00 (+184.36%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.20% | +4.71% | +4.46% | -1.40% | +17.22% | +5.50% | +74.38% | -93.14% | -98.10% | -99.83% | -99.83% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$4.22
102 sh
Bid
$4.01
1,200 sh
Ask
$4.50
500 sh
Spread
$0.490
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Recent analyst activity
DB- Jun 02, 2026PT$12.00X4 Pharmaceuticals initiated with an Outperform at LeerinkLeerink Partners
Peers
No peer list available for XFOR.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|